Myelodysplasia
Also known as: MDS / Myelodysplastic Syndrome / Myelodysplastic Syndromes / Myelodysplastic disease / Myelo Dysplastic Syndrome / Preleukemia / MYELODYSPLASTIC SYNDROME; MDS / MDS (Myelodysplastic Syndrome) / Myelodysplastic Syndrome(MDS) / Myelodysplastic Syndromes (MDS) / Myelodysplastic Disorders / Myeloid Dysplastic Syndrome / Myelodysplastic Syndrome (MDS) / Myelodysplastic Syndrome MDS / Myeldysplastic Syndrome (MDS) / Myelodysplastic Syndromes(MDS) / Other microdeletions / Miller-Dieker syndrome / Lissencephaly Syndrome, Miller-Dieker / Miller Dieker syndrome (disorder) / Lissencephaly (disorder) / Myelodysplastic syndrome, unspecified / Myeloid dysplasia / Myelodysplastic syndrome NOS / Myelodysplastic neoplasm (morphologic abnormality) / Myelodysplastic syndrome (disorder) / Preleukaemia
Drug | Drug Name | Drug Description |
---|---|---|
DB09312 | Antilymphocyte immunoglobulin (horse) | A primarily IgG immune globulin used to manage allograft rejection in renal transplant patients. |
DB15694 | Cedazuridine | A cytidine deaminase inhibitor coadministered with the hypomethylating agent decitabine for the treatment of variable forms of myelodysplastic syndrome (MDS). |
DB01262 | Decitabine | A chemotherapeutic pyrimidine nucleoside analogue used for the treatment of myelodysplastic syndromes (MDS) by inducing DNA hypomethylation and corresponding alterations in gene expression. |
DB00619 | Imatinib | A tyrosine kinase inhibitor used to treat a number of leukemias, myelodysplastic/myeloproliferative disease, systemic mastocytosis, hypereosinophilic syndrome, dermatofibrosarcoma protuberans, and gastrointestinal stromal tumors. |
DB00480 | Lenalidomide | A thalidomide derivative used to treat multiple myeloma and anemia in low to intermediate risk myelodysplastic syndrome. |